NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution
J. Biau, Xavier Durando, Fabien Boux, Ioana Molnar, J. Moreau, Brice Leyrat, F. Guillemin, Audrey Lavielle, Yannick Crémillieux, K. Seddik, S. Dufort, O. de Beaumont, Emilie Thivat, G. Le Duc
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.